原名「台灣學術線上」
包含TAO期刊庫 + TAO書籍庫 + 論文 + 史料文獻
首頁 | 關於TAO | 瀏覽 | 進階查詢 | 參考工具 | 會員服務 | 已購專書 | RSS服務 | 電子報 | FAQ  
查詢範圍:
   
查詢模式:
熱門查詢詞:
老人需求dvdTaiwan vet雞濾泡顆粒細胞
   
   
   
     
   
 
項次 書目
1
題名:使用電子影像驗證裝置在弧形強度調控放射治療的驗證     (16點)
DOSIMETRY VERIFICATION OF RAPIDARC VOLUMETRIC MODULATED ARC THERAPY WITH ELECTRONIC PORTAL IMAGING DEVICE
著者:李秉倫(Pin-Lun Li) ;鄭梅君(Mei-Chun Cheng) ;趙良曉(Liang-Hsiao Chao) ;劉晉昇(Ching-Sheng Liu) ;劉雪君(Shueh C. Liou) ;李玉麟(Yuh-Lin Lee) ;劉裕明(Yu-Ming Liu) ;王令瑋(Ling-Wei Wang) ;顏上惠(Sang-Hue Yen) ;黃英強(David YC Huang) ;陳信雄(Hsin-Hsiung Chen) ;趙敏(Max M. Chao)
出版地區:台灣
出版城市:台北市
學科:醫學綜合
關鍵字:電子影像驗證裝置 ; 加馬吻合指數 ; 弧形強度調控放射治療 ; 劑量驗證 ; Electronic Portal Imaging Device (EPID) ; Gamma Agreement Index (GAI) ; Volumetric Modulated Arc Therapy (VMAT) ; Dosimetry Verification
刊名:放射治療與腫瘤學
頁碼:49-56
語言:繁體中文
摘要: 中文摘要PDF ; 英文摘要PDF

目的:使用電子影像驗證裝置(EPID, VARIAN aS-1000)設備,配合Epiqa劑量驗證軟體來驗證弧形強度調控治療計畫的劑量分布。
材料與方法:Epiqa是一套基於GLAaS理論將電子影像驗證裝置影像轉換成劑量圖(dose map)的軟體,可用來驗證弧形強度調控(RapidArc)放射治療。將劑量影像轉換為劑量圖,必需透過校正的程序取得不同大小開放照野及穿透照野(transmission field)的影像,並輸入使用游離腔測量的輸出因子係數表;建立電子影像驗證裝置每一個像素(pixel)的校正因子,將像素的讀值轉換為在水中dmax深處的劑量。透過這樣的轉換,可以將電子影像驗證裝置的所有像素轉換成在水中dmax深度處的平面劑量分布圖;便可將治療計畫與電子影像驗證裝置兩者劑量分布比對進而與之驗證。本研究針對20位弧形強度調控放射治療案例進行劑量驗證,其中有7位攝護腺癌、2位乳癌、3位直腸癌、4位鼻咽癌與4位其它部位。
結果:電子影像驗證裝置劑量參數的加馬值(Gamma Agreement Index, GAI)設定吻合距離(DTA)為3毫米,劑量差異(ΔD)3%下,病患的平均GAI[%]為94.32±3.19 (99.06-81.31),而攝護腺癌、乳癌、直腸癌、鼻咽癌與其它部位的平均GAI[%]分別為93.62±4.03 (99.06-81.31)、97.43±1.14 (98.86-96.24)、92.96±2.51 (97.19-89.01)、94.98±2.31 (97.64-89.09)與94.95±2.48 (98.9-90.76),乳癌的GAI[%]呈現較好的結果(最低值達到96.24),其中攝護腺癌的1位患者在3個Arc中,有2個Arc的GAI[%]值在90%以下。
結論:利用Epiqa這套軟體驗證治療計畫運算所得的劑量,作為劑量驗證的工具是一種簡單且可行的的方法,希望累積更多臨床的驗證資料,使未來劑量驗證的程序更加理想。
Purpose: Verification of dose distributions for RapidArc Volumetric Modulated Arc Therapy (VMAT) treatment plans with Electronic Portal Imaging Device (EPID) and its associated software.
Materials and Methods: Epiqa is software to covert the EPID images into dose map based on the GLAaS theory. It can be used to verify the dose distributions for RapidArc therapy. To convert images into dose map, we need to have calibration factors for each pixel to covert the pixel values into dmax dose in water. For the purpose of calibration, a set of integrated images for open and transmission fields of different field sizes are acquired and consequently imported into Epiqa together with the output factor table to establish basic algorithm configuration data. A calibration factor can then be determined for every pixel of EPID images by weighting the contribution of primary and transmitted radiation. The pixel based calibration relates the readout of a pixel to a dose at the depth of dmax in water equivalent homogenous medium. By applying the conversion factors to all pixels of the EPID images, a planar dose distribution at the dmax in water is obtained. A total of 20 patients (70 arcs in total) were included in this study, 7 with prostate cancers, 2 with breast cancer, 4 with rectal cancer, 4 with NPC, and 4 with other sites.
Results: The Distance to Agreement (DTA) and the Dose Difference (ΔD) for The Gamma Agreement Index (GAI) of dosimetry parameters with EPID were set as 3 mm and less than 3% respectively. The average GAI (%) of patients in our study is 94.32±3.19 (99.06-81.31). GAI (%) for prostate cancer, breast cancer, rectal cancer, NPC, and other sites is 93.62±4.03 (99.06-81.31), 97.43±1.14 (98.86-96.24), 92.96±2.51 (97.19-89.01), 94.98±2.31 (97.64-89.09), and 94.95±2.48 (98.9-90.76), respectively. The GAI (%) for breast cancer had a better result, with a lowest value of 96.24. For one of the prostate cancer patient treated with 3 arcs, there are two arcs had a GAI value below 90%.
Conclusions: It is an easy and feasible way to apply the EPID with Epiqa software as dosimetry verification tool for VMAT. We will gather more clinical data to come out a better dosimetry verification procedure for VMAT in the near future.


    

本卷期目次
放射治療與腫瘤學
ADVANCED THYMIC CARCINOMA: CLINICAL EXPERIENCE AND PROGNOSTIC FACTORS OF 18 PATIENTS/ Chao-Yueh FanYee-Min JenWen-Yen HuangChang-Ming ChenHsing-Lung ChaoChun-Shu LinYu-Fu SuKuen-Tze LinJang-Chun LinCheng-Hsiang Lo
FEASIBILITY STUDY USING PRE-OPERATIVE PRONE-POSITION VOLUMETRIC MODULATED ARC THERAPY AND CHEMOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER/ Chia-Chun WangChiao-Ling TsaiYu-Hsuan ChenJin-Tung LiangMing-Jium ShiehBen-Ren LinYu-Lin LinJason Chia-Hsien Cheng
DOSIMETRIC COMPARISON OF TREATMENT PLANS BETWEEN INTENSITY-MODULATED RADIOTHERAPY, INTENSITY-MODULATED ARC THERAPY AND HELICAL TOMOTHERAPY FOR TOTAL SCALP IRRADIATION/ Chin-Nan ChuChun-Yen YuWen-Tsen ChouShih-Neng YangJi-An LiangShang-Wen Chen
模擬頭頸部病人強度調控放射治療皮膚劑量之假體研究/ 傅筱如羅素花曾玉華徐椿壽蔡維達
PTW 2d-array於強度調控放射治療及體積調控弧形治療劑量驗證之經驗分享/ 洪照雄劉國基陳弘政黃英強賴家玄陳妙芬陳文政
使用電子影像驗證裝置在弧形強度調控放射治療的驗證/ 李秉倫鄭梅君趙良曉劉晉昇劉雪君李玉麟劉裕明王令瑋顏上惠黃英強陳信雄趙敏
放射腫瘤科門診病患接受跨院區轉介之意見調查/ 翁麗慧蔡介生
GENE SEQUENCING FOR SELECTION OF CHEMOTHERAPY DRUGS COMBINED WITH STEREOTACTIC BODY RADIATION THERAPY FOR STAGE IV COLON CANCER: A CASE REPORT/ Yaoru HuangShang-Wen ChenLai-Lei TingChia-Chun KuoJeng-Fong Chiou
 
   
 
   

與TAO合作 | 隱私與版權聲明 | 聯絡方式 | 下載Adobe Reader
地址:台北市中正區(100)北平東路30-12號3樓
電話:(02)2393-6968 傳真:(02)2393-6877
Email: service@wordpedia.com
Wordpedia Family: 學校、企業版入口 | 遠流影音館
Copyright©2011 Wordpedia Co., Ltd. All Rights Reserved.